Jose Manuel Sousa Lobo
Overview
Explore the profile of Jose Manuel Sousa Lobo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
611
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Torres J, Silva R, Farias G, Sousa Lobo J, Ferreira D, Silva A
Pharmaceutics
. 2024 Oct;
16(10).
PMID: 39458626
Migraine has a high prevalence worldwide and is one of the main disabling neurological diseases in individuals under the age of 50. In general, treatment includes the use of oral...
2.
Silva A, Moreira J, Sousa Lobo J
Pharmaceuticals (Basel)
. 2023 Dec;
16(12).
PMID: 38139826
Among the different types of nanosystems that have been investigated for therapeutic use, lipid-based ones are the most explored, as they have advantages over non-lipid nanosystems, especially for improving the...
3.
Pina Costa C, Nodilo L, Silva R, Martins E, Zadravec D, Kalogjera L, et al.
Int J Pharm
. 2023 Aug;
644:123345.
PMID: 37619806
The nasal route has been investigated as a promising alternative for drug delivery to the central nervous system, avoiding passage through the blood-brain barrier and improving bioavailability. In this sense,...
4.
Torres J, Costa I, Peixoto A, Silva R, Sousa Lobo J, Silva A
Pharmaceuticals (Basel)
. 2023 Jun;
16(2).
PMID: 37259454
Marine sources contain several bioactive compounds with high therapeutic potential, such as remarkable antioxidant activity that can reduce oxidative stress related to the pathogenesis of neurodegenerative diseases. Indeed, there has...
5.
Torres J, Pereira J, Marques-Oliveira R, Costa I, Gil-Martins E, Silva R, et al.
Pharmaceutics
. 2023 Apr;
15(4).
PMID: 37111521
The intranasal route has been suggested as a promising alternative to improve the direct transport of molecules to the brain, avoiding the need to cross the blood-brain barrier (BBB). In...
6.
Ogbonna J, Cunha E, Attama A, Ofokansi K, Ferreira H, Pinto S, et al.
Pharmaceuticals (Basel)
. 2022 Nov;
15(11).
PMID: 36355503
Designing oral formulations for children is very challenging, especially considering their peculiarities and preferences. The choice of excipients, dosing volume and palatability are key issues of pediatric oral liquid medicines....
7.
Silva A, Moreira J, Sousa Lobo J
Pharmaceuticals (Basel)
. 2022 Oct;
15(10).
PMID: 36297379
Lipid-based nanosystems, including solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC), cationic lipid nanoparticles, nanoemulsions and liposomes, have been extensively studied to improve drug delivery through different administration routes...
8.
Teixeira A, Ribeiro C, Gaio R, Torres T, Magina S, Pereira T, et al.
J Psychosom Res
. 2022 Jan;
154:110714.
PMID: 35007943
Objectives: The psychosocial impact of psoriasis is well documented. However, the contributing role of clinical disease characteristics is not satisfactorily explored. This study aimed to validate the Self-administered Psoriasis Area...
9.
Batista J, Torre C, Sousa Lobo J, Sepodes B
Hum Resour Health
. 2022 Jan;
20(1):3.
PMID: 34991616
Background: The Portuguese Pharmaceutical Society (PPS) implemented a system of Continuous Professional Development (CPD) for pharmacists in 2004. This system has evolved throughout the years, and currently all active pharmacists...
10.
Pina Costa C, Barreiro S, Moreira J, Silva R, Almeida H, Sousa Lobo J, et al.
Pharmaceuticals (Basel)
. 2021 Aug;
14(8).
PMID: 34451808
The nasal route has been used for many years for the local treatment of nasal diseases. More recently, this route has been gaining momentum, due to the possibility of targeting...